Why the study?
The clinical implications of diagnosing Brugada syndrome exclusively at higher intercostal spaces remained poorly understood.
Does the use of higher intercostal space electrocardiography improve the diagnostic rate of Brugada syndrome compared to standard intercostal space, and do these patients differ in clinical prognosis?
Does the use of higher intercostal space electrocardiography improve the diagnostic rate of Brugada syndrome compared to standard intercostal space, and do these patients differ in clinical prognosis?
Using higher intercostal leads significantly increases the diagnosis rate of Brugada syndrome by identifying an additional 43.6% of patients, who share a similar clinical prognosis to those diagnosed with standard leads.
Answers are grounded in this paper and cite their sources.
Higher ICS ECG may aid Brugada evaluation; leaves open whether added diagnoses change management or outcomes.
Diagnosis of Brugada syndrome (BrS) is based on type 1 morphology (coved type) in electrocardiograms from standard (4 th ) or higher (2 nd or 3 rd ) intercostal spaces (ICSs). However, the clinical implications of being diagnosed only at higher ICSs remains poorly understood. We aimed to investigate the diagnostic accuracy of higher ICS leads in the Taiwanese Brugada syndrome population and clarify if there is any difference in clinical presentation. Patients enrolled in the Sudden Arrhythmic Death Syndrome-Taiwan (SADS-TW) registry from 2010/01/01 to 2021/07/30 were retrospectively reviewed. Records were examined for 163 patients whose ECGs in the 2 nd , 3 rd , and/or 4 th ICSs showed a type 1 BrS pattern in at least 1 lead. Baseline characteristics, family history, clinical presentation, SCN5A mutation status, cardiovascular events, and mortality were analyzed. Using the standard ICS alone, 56.4% patients could be diagnosed with BrS, whereas the remaining 43.6% of patients could only be diagnosed using higher ICSs. The mean age of diagnosis using higher ICSs was 42.2 ± 14.7 years vs. 46.8 ± 14.6 years in patients diagnosed using the standard ICSs (p = 0.048). Hypertension was more prevalent in patients diagnosed by standard ICSs (27.2%) vs. patients diagnosed by higher ICSs (4.2%; p < 0.001). No differences were observed in family history, clinical presentation, SCN5A mutation status, cardiovascular events, or mortality (mean follow-up time = 3.96 ± 3.45 years, p = 0.28). Using higher intercostal leads could significantly increase the diagnosis rate of BrS in the Taiwanese population, although it would not affect the clinical prognosis.
No takes yet. Share an insight, caveat, or question.
Tseng et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: